Insider trades
Michael A. Mussallem, Director of Edwards Lifesciences EW, has filed 0 purchases and 37 sales on the open market. The latest trade was on 24/05/02.
Michael A. Mussallem
Director
- Company
- Edwards Lifesciences EW
- First filing
- 23/01/13
- Trades
- 91 trades
- Buys / sales
- 0 / 37
- 12-month net buying
- No record
- Last trade
- 24/05/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 24/05/02 | 24/05/02 | 29,350 sh2 trades | $84.77avg. | $2,487,965.51 | −86.7% | |
| Open-market sale10b5-1 plan | 24/04/04 | 24/04/04 | 29,350 sh4 trades | $92.42avg. | $2,712,418.04 | −86.7% | |
| Open-market sale10b5-1 plan | 24/03/04 | 24/03/04 | 29,350 sh2 trades | $86.67avg. | $2,543,737.1 | −86.7% | |
| Open-market sale10b5-1 plan | 24/02/05 | 24/02/05 | 29,350 sh4 trades | $87.49avg. | $2,567,753.55 | −86.7% | |
| Open-market sale10b5-1 plan | 24/01/05 | 24/01/05 | 29,350 sh2 trades | $72.98avg. | $2,142,089 | −86.7% | |
| Open-market sale10b5-1 plan | 23/12/13 | 23/12/13 | 29,350 sh4 trades | $74.62avg. | $2,190,043.08 | −86.7% | |
| Open-market sale10b5-1 plan | 23/11/03 | 23/11/06 | 29,350 sh | $67.18 | $1,971,733 | −86.7% | |
| Open-market sale10b5-1 plan | 23/10/02 | 23/10/02 | 29,350 sh | $68.84 | $2,020,454 | −86.7% | |
| Open-market sale10b5-1 plan | 23/09/05 | 23/09/05 | 29,350 sh | $75.86 | $2,226,491 | −86.7% | |
| Open-market sale10b5-1 plan | 23/08/07 | 23/08/07 | 29,350 sh2 trades | $79.87avg. | $2,344,095 | −35.1% | |
| Open-market sale10b5-1 plan | 23/07/05 | 23/07/05 | 29,350 sh2 trades | $90.78avg. | $2,664,487.48 | −35.1% | |
| Open-market sale10b5-1 plan | 23/06/01 | 23/06/01 | 29,350 sh3 trades | $84.46avg. | $2,478,839.46 | −25.4% | |
| Open-market sale10b5-1 plan | 23/05/10 | 23/05/11 | 19,875 sh2 trades | $88.49avg. | $1,758,653.35 | −19.6% | |
| Open-market sale10b5-1 plan | 23/04/14 | 23/04/17 | 19,875 sh2 trades | $84.20avg. | $1,673,433.66 | −24.6% | |
| Open-market sale | 23/03/14 | 23/03/14 | 19,875 sh2 trades | $77.61avg. | $1,542,513 | −24.6% | |
| Open-market sale | 23/02/14 | 23/02/14 | 19,875 sh2 trades | $77.00avg. | $1,530,308.25 | −11.2% | |
| Open-market sale | 23/01/13 | 23/01/13 | 19,875 sh | $78.09 | $1,552,038.75 | −11.2% |